Abide Therapeutics partners with Oxford University on new drug targets
As part of the deal, Abide and Oxford will study the role of monoacylglycerol lipase (MGLL) inhibitors in altering endocannabinoid tone in the human brain. The partnership will
Bristol Myers Squibb (BMS) is set to merge its separate research and development (R&D) departments into a single entity, effective from 1 January 2027.
An active moiety of the prodrug isavuconazonium, Isavuconazole is an investigational once-daily intravenous and oral broad-spectrum antifungal being developed to treat severe invasive and life-threatening fungal infections. The
These data demonstrate that Fluzone High-Dose vaccine provided improved protection against influenza ("the flu") compared to standard-dose Fluzone vaccine (trivalent intramuscular formulation) in adults 65 years of age
The effectiveness of aripiprazole once-monthly (aripiprazole extended-release injectable suspension, for intramuscular use: Abilify Maintena) and paliperidone palmitate (paliperidone palmitate extended-release injectable suspension, for intramuscular use) in adult patients